1. Home
  2. TCRX vs IH Comparison

TCRX vs IH Comparison

Compare TCRX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

HOLD

Current Price

$1.11

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.65

Market Cap

85.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCRX
IH
Founded
2018
1996
Country
United States
China
Employees
N/A
558
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
75.1M
85.6M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
TCRX
IH
Price
$1.11
$1.65
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
937.1K
7.4K
Earning Date
05-08-2026
03-31-2026
Dividend Yield
N/A
5.88%
EPS Growth
12.28
N/A
EPS
N/A
N/A
Revenue
$10,325,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$19.81
N/A
P/E Ratio
N/A
$7.30
Revenue Growth
266.65
N/A
52 Week Low
$0.88
$1.55
52 Week High
$2.57
$3.60

Technical Indicators

Market Signals
Indicator
TCRX
IH
Relative Strength Index (RSI) 44.12 43.10
Support Level $0.93 $1.55
Resistance Level $1.21 $1.83
Average True Range (ATR) 0.10 0.07
MACD -0.02 -0.00
Stochastic Oscillator 5.27 19.55

Price Performance

Historical Comparison
TCRX
IH

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

Share on Social Networks: